J Clin Psychiatry 2011;72(6):874 [letter]
© Copyright 2015 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
In the article “Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications” by Ni A. Khin, MD, and colleagues published in the April 2011 issue (J Clin Psychiatry 2011;72:464–472), the legend for Figures 1, 2A, and 3 has been corrected online to “Δ Trial with mean baseline HDRS score < 20” and “¦ Trial with mean baseline HDRS score = 20”; and the legend for Figure 2B has been corrected to “¦ Trial with mean baseline HDRS score = 20.” The staff regret the errors.